The modulation of NRPs with specific inhibitors seems to be a promising approach for cancers therapy due to its role in angiogenesis, tumor progression, and fibrosis, with potential treatments including NRP-1 antagonists, CAR-T cell therapy, and siRNA delivery using polymeric nanoparticles. This evidence concerns the gene NRP1 and neoplasm.